Valuation: GSK plc

Market Cap 79.02B 106B 92.42B 85.13B 150B 10,066B 152B 1,019B 397B 4,941B 396B 388B 17,131B P/E 2026 *
12.7x
P/E 2027 * 11.7x
Enterprise Value 94.45B 126B 110B 102B 179B 12,032B 182B 1,218B 474B 5,906B 474B 463B 20,477B EV / Sales 2026 *
2.79x
EV / Sales 2027 * 2.56x
Free-Float
92.29%
Yield 2026 *
3.51%
Yield 2027 * 3.7%
1 day+1.34%
1 week+1.56%
Current month+1.56%
1 month+5.18%
3 months-4.01%
6 months+5.81%
Current year+10.28%
1 week 1,930
Extreme 1930
2,049
1 month 1,839
Extreme 1839
2,049
Current year 1,690
Extreme 1690
2,282
1 year 1,288.6
Extreme 1288.6047
2,282
3 years 1,242.5
Extreme 1242.5
2,282
5 years 1,242.5
Extreme 1242.5
3,408.16
10 years 1,242.5
Extreme 1242.5
3,408.16
Manager TitleAgeSince
Chief Executive Officer - 01/01/2026
Director of Finance/CFO 64 01/05/2023
Chief Tech/Sci/R&D Officer - 01/12/2021
Director TitleAgeSince
Director/Board Member - 06/05/2026
Director/Board Member 64 01/01/2018
Chairman 68 01/09/2019
Date Insider Type Main position Quantity % Market Cap.
06-22Buy

Executive/Senior Manager

9 0.0000%
06-08Buy

Executive/Senior Manager

9 0.0000%
05-22Buy

Executive/Senior Manager

9 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.29%+1.56%+44.18%+52.89% 106B
+2.90%+3.00%+59.85%+173.28% 1,070B
+3.53%+5.64%+72.80%+68.48% 624B
+1.09%+2.77%+37.84%+90.86% 450B
-0.69%+0.53%+31.00%+25.82% 328B
+2.24%+2.06%+40.83%+42.33% 292B
+1.33%+0.08%+29.78%+49.19% 284B
+1.98%+4.02%-25.83%-39.06% 217B
+1.41%+2.56%+26.78%+69.86% 198B
+4.25%+7.17%+21.13%+81.94% 161B
Average +1.96%+0.98%+33.84%+61.56% 372.99B
Weighted average by Cap. +2.23%+0.76%+44.19%+87.93%

Financials

2026 *2027 *
Net sales 33.86B 45.23B 39.61B 36.48B 64.31B 4,314B 65.18B 437B 170B 2,118B 170B 166B 7,342B 35.59B 47.53B 41.63B 38.34B 67.59B 4,534B 68.5B 459B 179B 2,226B 179B 175B 7,716B
Net income 6.47B 8.65B 7.57B 6.97B 12.29B 825B 12.46B 83.48B 32.49B 405B 32.47B 31.75B 1,403B 6.94B 9.27B 8.12B 7.48B 13.18B 884B 13.35B 89.48B 34.82B 434B 34.8B 34.04B 1,504B
Net Debt 15.43B 20.61B 18.05B 16.62B 29.3B 1,966B 29.7B 199B 77.45B 965B 77.4B 75.7B 3,346B 12.24B 16.34B 14.31B 13.18B 23.24B 1,559B 23.55B 158B 61.41B 765B 61.37B 60.03B 2,653B
Logo GSK plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
66,841
Date Price Change Volume
07/07/26 GBX 2,011.00 +1.41% 982,652
06/07/26 GBX 1,983.00 -1.59% 15,158,597
03/07/26 GBX 2,015.00 +0.55% 2,548,759
02/07/26 GBX 2,004.00 +3.83% 17,567,408
01/07/26 GBX 1,930.00 -2.57% 8,818,924
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
19.83GBP
Average target price
21.14GBP
Spread / Average Target
+6.62%

Quarterly revenue - Rate of surprise